The 2^nd International Conference on Translational Medicine (Translational Medicine-2013) took place at the Holiday Inn Chicago-North shore, USA during August 5-7, 2013. It was organized by OMICS Group and saw a good response from the scientific community. The three day program witnessed thought provoking speeches from experts which focused on the theme "Exploring New Horizons of Translational Medicine".

Sigma-Aldrich Co. LLC. proudly sponsored the event and showcased their new innovations.

The highlights of the meeting were the eponymic Keynote lectures from

• Maurizio Chiriva Internati - Texas Tech University, USA
• Michael Retsky - Harvard School of Public Health, USA
• Antonio Gomez Munoz - University of the Basque Country, Spain
• Gerson Chadi - University of Sao Paulo, Brazil

Organizations from various countries took part in the conference. Some of them were

• Biodesix, Inc., USA
• GlaxoSmithKline, USA
• Recombinant By Deloitte, USA
• Celgene Cellular  Therapeutics, USA
• Cedars-Sinai Medical Center, USA
• ProFibrix, Inc., USA
• Frohna Biotech Consulting, USA
• The Wisconsin Parkinson Association, USA
• Ako Kasei co., Ltd, Japan

Translational Medicine-2013 played an important role in promoting multidisciplinary interactions between science and medicine to enhance disease research and drug development. The program covered current and emerging challenges in the biopharmaceutical industry and strategies for drug development.

We are obliged to the various delegates from companies and institutes who actively took part in the discussions. We sincerely thank all the Organizing Committee Members of Translational Medicine-2013 for their support throughout the planning of this conference. With valuable feedback from the conference, OMICS Group would like to announce the commencement of "3^rd International Conference on Translational Medicine" September 24-26, 2014 Valencia, Spain.